Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Visceral leishmaniasis can mimic rheumatoid arthritis symptoms, especially in immunocompromised patients.

Tumor cells in calcifying epithelioma of Malherbe resemble hair follicle cells.

A high-fat diet worsens neutrophilic folliculitis by increasing certain chemokines.

Mast cells and the CB1 receptor may be key in causing IgA vasculitis.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Keloid fibroblasts cause itch and pain by releasing more histamine.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

Blocking the HEDGEHOG-GLI1 pathway can reduce keloid growth and may be a potential treatment.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

A patient in Portugal with chronic pulmonary histoplasmosis had a complex medical history and environmental exposures.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.